Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics:
- Key data management elements in clinical trials for oncological therapeutics
- Prospects for therapeutic targeting of microRNAs in brain tumors
- Breast cancer vaccines: current status and future approach
- Desmocollin-3 and cancer
- MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53
- Towards targeted therapy: anticancer agents targeting cell organelle mitochondria
- Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults
Audience: Pharmaceutical Scientists, Medicinal Chemists, Clinical Oncologists, Researchers in Pre-clinical studies and clinical trials
© 2006 Bentham Science (undefined): 9781681089317
undefined: 2006년 5월 22일
Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics:
- Key data management elements in clinical trials for oncological therapeutics
- Prospects for therapeutic targeting of microRNAs in brain tumors
- Breast cancer vaccines: current status and future approach
- Desmocollin-3 and cancer
- MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53
- Towards targeted therapy: anticancer agents targeting cell organelle mitochondria
- Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults
Audience: Pharmaceutical Scientists, Medicinal Chemists, Clinical Oncologists, Researchers in Pre-clinical studies and clinical trials
© 2006 Bentham Science (undefined): 9781681089317
undefined: 2006년 5월 22일
격이 다른 오디오북 생활을 경험해보세요!
아직 리뷰가 없습니다
대화에 참여하고 리뷰를 추가하려면 앱을 다운로드하세요.
한국어
대한민국